References
- Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol. 1998;20(5):451–457. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9787318 doi: https://doi.org/10.1097/00043426-199809000-00008
- van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006;20(10):1717–1722. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16888619 doi: https://doi.org/10.1038/sj.leu.2404326
- Kovacs GT, Barany O, Schlick B, et al. Late immune recovery in children treated for malignant diseases. Pathol Oncol Res. 2008;14(4):391–397. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18575827 doi: https://doi.org/10.1007/s12253-008-9073-5
- Perkins JL, Harris A, Pozos TC. Immune dysfunction after completion of childhood leukemia therapy. J Pediatr Hematol Oncol. 2017;39(1):1–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27820131 doi: https://doi.org/10.1097/MPH.0000000000000697
- Koochakzadeh L, Khosravi MH, Pourakbari B, et al. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2014;31(7):656–663. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25007393 doi: https://doi.org/10.3109/08880018.2013.877111
- Bochennek K, Allwinn R, Langer R, et al. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine. 2014;32(27):3357–3361. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24793952 doi: https://doi.org/10.1016/j.vaccine.2014.04.042
- Aytac S, Yalcin SS, Cetin M, et al. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2010;27(5):333–343. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20469978 doi: https://doi.org/10.3109/08880011003767720
- Zengin E, Sarper N. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. Pediatr Blood Cancer. 2009;53(6):967–972. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19544393 doi: https://doi.org/10.1002/pbc.22135
- Patel SR, Ortín M, Cohen BJ, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007;44(5):635–642. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17278052 doi: https://doi.org/10.1086/511636
- Ercan TE, Soycan LY, Apak H, et al. Antibody titers and immune response to diphtheria–tetanus–pertussis and measles–mumps–rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27(5):273–277. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15891564 doi: https://doi.org/10.1097/01.mph.0000163214.37147.5a
- Brodtman DH, Rosenthal DW, Redner A, et al. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr. 2005;146(5):654–661. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15870670 doi: https://doi.org/10.1016/j.jpeds.2004.12.043
- Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101(3):635–641. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15274078 doi: https://doi.org/10.1002/cncr.20384
- Nilsson A, De Milito A, Engström P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109(6):e91. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12042585 doi: https://doi.org/10.1542/peds.109.6.e91
- Smith S, Schiffman G, Karayalcin G, et al. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin–Frankfurt–Münster therapy. J Pediatr. 1995;127(1):68–75. Available from: https://www.ncbi.nlm.nih.gov/pubmed/7608814 doi: https://doi.org/10.1016/S0022-3476(95)70259-8
- Esposito S, Prada E, Lelii M, et al. Immunization of children with secondary immunodeficiency. Hum Vaccin Immunother. 2015;11(11):2564–2570. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26176360 doi: https://doi.org/10.1080/21645515.2015.1039208
- Haralambieva IH, Kennedy RB, Ovsyannikova IG, et al. Variability in humoral immunity to measles vaccine: new developments. Trends Mol Med. 2015;21(12):789–801. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26602762 doi: https://doi.org/10.1016/j.molmed.2015.10.005